Brain Cancer Drug Leads to $935M Jazz Pharma Acquisition
Exploring Innovative Treatments for Brain Cancer: Jazz Pharmaceuticals’ $935 Million Commitment Brain […]
AstraZeneca Acquires FibroGen Unit for Anemia Drug Rights in China
Major Pharmaceutical Deal: AstraZeneca Expands Control Over Roxadustat in China A significant […]